Chemotherapy-Induced Thrombocytopenia: Symptoms, Causes, Treatment
نقص الصفائح أثناء العلاج الكيميائي
Low platelets during chemotherapy reduce the ability to stop bleeding. Risk depends on the count, its trend, active bleeding and other factors, rather than bruising alone.
What is Chemotherapy-Induced Thrombocytopenia?
Platelets help form an initial plug at an injury. Thrombocytopenia differs from neutropenia and anemia, although these blood-count problems can occur together.
Related reading: Anemia during cancer treatment.
Symptoms
Easy bruising, tiny red skin spots, nose or gum bleeding and heavier periods may occur. Sometimes a routine blood test detects low platelets before symptoms appear.
Causes
Treatment may slow platelet production in the marrow. Cancer, infection, immune or liver disorders and medicines can also contribute and need consideration.
Risk factors
Severe or persistent low counts, fever, blood thinners, liver disease and planned surgery influence risk. Tell the team about previous abnormal bleeding.
Diagnosis
Assessment includes the blood-count trend, treatment timing, medicines and bleeding history. A blood smear or additional investigations may be needed when the cause is uncertain.
Treatment
Platelet transfusion or a treatment delay may be appropriate according to bleeding, count and planned procedures. Platelet-stimulating drugs are selected specialist options, not universal treatment.
Complications
Serious or internal bleeding and treatment delays can occur. Transfusion decisions depend on clinical context; a single home threshold cannot safely cover every patient.
Prevention
Use a soft toothbrush and avoid injuries. Check before using aspirin, anti-inflammatory painkillers or supplements; do not independently stop a prescribed blood thinner.
When to see a doctor
Bleeding that persists despite pressure, vomiting blood, black stools, severe new headache or confusion needs urgent care. Report a head injury promptly.